// App-Quantinova.ai

1401 : Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada

Researchers

Presenter

  • Alina S. Gerrie

Principal Investigators

  • Steven J.T. Huang

  • Khaled M Ramadan

  • Aly Karsan

  • Monica Anne Hrynchak

  • Chinmay B. Dalal

  • Helene Bruyere

  • Adam C. Smith

  • Cynthia L. Toze

  • Tanya L. Gillan

Medical Centers

  • Leukemia/BMT Program of BC, Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Division of Hematology, University of British Columbia, Leukemia/Bone Marrow Transplant Program, Vancouver, Canada

  • Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, BC, Canada

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • St. Pauls Hospital, University of British Columbia, Vancouver, BC, Canada

  • Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada

  • Cytogenetics Laboratory, Royal Columbian Hospital, New Westminster, BC, Canada

  • British Columbia Cancer Research Center, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Cluster of Differentiation 38

  • Immunoglobulin heavy-chain variable region gene

  • White Blood Cell

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • chlorambucil

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved